Overview
RegCell, Inc., an Emeryville, CA-based biotechnology company developing therapies to restore immune tolerance, raised $66M in total funding, including a $44M Series A financing and a $22M non-dilutive grant from Japan’s Agency for Medical Research and Development (AMED). The Series A round was led by Playground Global with participation from Global Brain, Mitsui Chemicals, LG Technology Ventures, Alumni Ventures, Medical Incubator Japan, Fast Track Initiative, The University of Tokyo Edge Capita...See more
Website
https://regcellbio.com/Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
$66.0M • Funding Round
Announced on 9/15/2026
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.